These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 12612874

  • 21. Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure.
    Koda M, Takemura G, Kanoh M, Hayakawa K, Kawase Y, Maruyama R, Li Y, Minatoguchi S, Fujiwara T, Fujiwara H.
    J Pathol; 2003 Feb; 199(2):229-36. PubMed ID: 12533836
    [Abstract] [Full Text] [Related]

  • 22. Decreased expression of calmodulin mRNA in human end-stage heart failure.
    Jeck CD, Zimmermann R, Schaper J, Schaper W.
    J Mol Cell Cardiol; 1994 Jan; 26(1):99-107. PubMed ID: 8196073
    [Abstract] [Full Text] [Related]

  • 23. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH, de Jonge N, van Oosterhout MF, Van Wichen DF, de Koning E, Lahpor JR, Kemperman H, Gmelig-Meyling FH, de Weger RA.
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [Abstract] [Full Text] [Related]

  • 24. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J, Youker KA, Torre-Amione G, Koerner MM, Bruckner B, Noon GP, Loebe M.
    J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
    [Abstract] [Full Text] [Related]

  • 25. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S, Foronjy RF, Dickstein ML, Gu A, Garrelds IM, Danser AH, Oz MC, D'Armiento J, Burkhoff D.
    Circulation; 2005 Jul 19; 112(3):364-74. PubMed ID: 15998679
    [Abstract] [Full Text] [Related]

  • 26. Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes.
    Monego G, Arena V, Pasquini S, Stigliano E, Fiaccavento R, Leone O, Arpesella G, Potena L, Ranelletti FO, Di Nardo P, Capelli A.
    Basic Res Cardiol; 2009 Jul 19; 104(4):427-34. PubMed ID: 19190955
    [Abstract] [Full Text] [Related]

  • 27. [Changes of myocardial enzymes related to glycolysis and fatty acid metabolism in chronic myocardial ischemia: experiment with pigs].
    Gong J, Wang HY, Pu JL, Zheng YL, Shen R, Yang MF, He ZX.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 12; 88(31):2209-13. PubMed ID: 19080674
    [Abstract] [Full Text] [Related]

  • 28. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
    Szotowski B, Goldin-Lang P, Antoniak S, Bogdanov VY, Pathirana D, Pauschinger M, Dörner A, Kuehl U, Coupland S, Nemerson Y, Hummel M, Poller W, Hetzer R, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1081-9. PubMed ID: 15808768
    [Abstract] [Full Text] [Related]

  • 29. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function.
    Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, Maccherini M, Modesti PA.
    Circ Res; 2001 May 11; 88(9):961-8. PubMed ID: 11349007
    [Abstract] [Full Text] [Related]

  • 30. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy.
    Iyengar S, Haas G, Lamba S, Orsinelli DA, Babu GJ, Ferketich AK, Yamokoski L, Periasamy M, Abraham WT.
    J Card Fail; 2007 May 11; 13(4):304-11. PubMed ID: 17517351
    [Abstract] [Full Text] [Related]

  • 31. Myocardial infarction increases ACE2 expression in rat and humans.
    Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, Tikellis C, Grant SL, Lew RA, Smith AI, Cooper ME, Johnston CI.
    Eur Heart J; 2005 Feb 11; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
    [Abstract] [Full Text] [Related]

  • 32. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
    Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J, Bers DM, Brown JH.
    Circ Res; 2003 May 02; 92(8):912-9. PubMed ID: 12676814
    [Abstract] [Full Text] [Related]

  • 33. Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
    Weil J, Zolk O, Griepentrog J, Wenzel U, Zimmermann WH, Eschenhagen T.
    Cardiovasc Res; 2006 Feb 01; 69(2):412-22. PubMed ID: 16376326
    [Abstract] [Full Text] [Related]

  • 34. Increased expression and phosphorylation of focal adhesion kinase correlates with dysfunction in the volume-overloaded human heart.
    Lopes MM, Ribeiro GC, Tornatore TF, Clemente CF, Teixeira VP, Franchini KG.
    Clin Sci (Lond); 2007 Aug 01; 113(4):195-204. PubMed ID: 17497960
    [Abstract] [Full Text] [Related]

  • 35. Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy.
    Severino A, Campioni M, Straino S, Salloum FN, Schmidt N, Herbrand U, Frede S, Toietta G, Di Rocco G, Bussani R, Silvestri F, Piro M, Liuzzo G, Biasucci LM, Mellone P, Feroce F, Capogrossi M, Baldi F, Fandrey J, Ehrmann M, Crea F, Abbate A, Baldi A.
    J Am Coll Cardiol; 2007 Sep 11; 50(11):1029-37. PubMed ID: 17825711
    [Abstract] [Full Text] [Related]

  • 36. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, Towbin JA, Torre-Amione G.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):811-7. PubMed ID: 14998622
    [Abstract] [Full Text] [Related]

  • 37. Unloaded rat hearts in vivo express a hypertrophic phenotype of cardiac repolarization.
    Schwoerer AP, Melnychenko I, Goltz D, Hedinger N, Broichhausen I, El-Armouche A, Eschenhagen T, Volk T, Ehmke H.
    J Mol Cell Cardiol; 2008 Nov 03; 45(5):633-41. PubMed ID: 18721926
    [Abstract] [Full Text] [Related]

  • 38. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G.
    Circ Heart Fail; 2009 Nov 03; 2(6):624-32. PubMed ID: 19919988
    [Abstract] [Full Text] [Related]

  • 39. Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart.
    Heerdt PM, Klotz S, Burkhoff D.
    Anesth Analg; 2006 Jan 03; 102(1):32-7. PubMed ID: 16368801
    [Abstract] [Full Text] [Related]

  • 40. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure.
    El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh YH, Nattel S, Dobrev D, Eschenhagen T, Carrier L.
    J Mol Cell Cardiol; 2007 Aug 03; 43(2):223-9. PubMed ID: 17560599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.